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SUMMARY
Fourteen out of 150 (9.3%) consecutive strains of Haemophilus influenzae
isolated on culture of sputum in the Bacteriology Department, Belfast City
Hospital, during 1982/83 were found to be ampicillin-resistant (13-lactamase-
producing). Susceptibility testing to other antibiotics ofthese ampicillin-resistant
strains showed that cefuroxime, cefotaxime, gentamicin, and amoxycillin with
clavulanic acid were reliable alternatives. Other useful alternatives included
tetracycline, trimethoprim and co-trimoxazole. Erythromycin was of limited
usefulness.
INTRODUCTION
Haemophilus influenzae is an important pathogen in acute infective
exacerbations of chronic bronchitis. Until 1974, ampicillin had been regarded
as the drug of choice for treating these infective episodes as it was effective
against virtually all strains of Haemophilus influenzae. Since then many reports
have shown an increasing incidence of ampicillin-resistant strains of
Haemophilus influenzae in the United Kingdom.1 2 A large survey of antibiotic
resistance in the United Kingdom in 1981 2 showed that 6.2 % of 1,841 strains
were resistant to ampicillin. The percentage ranged from 0% in Stockport to
11.5 % in Portsmouth. The usual mechanism of ampicillin resistance in
Haemophilus influenzae is the production by the organism of an enzyme,
j3-lactamase, which inactivates the drug.3
To determine the current situation in Belfast, a study was carried out during the
winter of 1982.83 on strains of Haemophilus influenzae isolated from sputum.
METHODS
One hundred and fifty consecutive strains of Haemophilus influenzae isolated
from sputum were collected. Each strain was seeded on to a nutrient agar plate
and V, X and XV factor discs were placed on the surface. The plates were then
incubated in air at 370C for 18 hours. Organisms that grew around the XV disc
only (i.e. both X and V factor.dependent) were confirmed as Haemophilus
influenzae. All the strains identified as Haemophilus influenzae were tested for
J3.lactamase production using the chromogenic cephalosporin substrate
method.4
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Each strain was seeded on to a Diagnostic Sensitivity Test (DST Oxoid) chocolate
agar and filter paper discs containing ampicillin, tetracycline, erythromycin,
trimethoprim, sulphonamide, co-trimoxazole, amoxycillin with clavulanic acid,
cefuroxime and cefotaxime were applied to the surface. After incubation at 370C
for 18 hours, the zone sizes around the discs were measured and compared with
a control-sensitive strain.
RESULTS
Of the 150 strains collected, all satisfied the conditions set out above for
identification and were confirmed as Haemophilus influenzae. Fourteen out of
the 150 strains (9.3%) produced J3-lactamase and were designated ampicillin-
resistant. Tables 1 and 2 respectively show the resistance of the 14 ampicillin-
resistant and 136 ampicillin-sensitive strains of Haemophilus influenzae to 10
antibiotics. Resistance was defined as a zone size smaller than for the control by
more than 3 mm.
TABLE 1
Resistance of 14 ampicillin-resistant (13-lactamase-producing) strains of
Haemophilus influenzae to 10 antibiotics
Antibiotic No. Resistant (%) Antibiotic No. Resistant (%)
Ampicillin 14 (100%) Co-trimoxazole 3 (21 %)
Tetracycline 3 ( 21 %) Gentamicin 0 (0%)
Erythromycin 6 ( 43%) Amoxycillin/ 0 (0%)
Clavulanic acid
Trimethoprim 2 ( 14%) Cefuroxime 0 (0%)
Sulphonamide 3 ( 21 %) Cefotaxime 0 (0%)
TABLE 2
Resistance of 136 ampicillin-sensitive strains ofHaemophilus influenzae
to 10 antibiotics
Antibiotic No. Resistant (%) Antibiotic No. Resistant (%)
Ampicillin 0 ( 0%) Co-trimoxazole 8 (6%)
Tetracycline 8 ( 6%) Gentamicin 0 (0%)
Erythromycin 54 (40%) Amoxycillin/ 0 (0%)
Clavulanic acid
Trimethoprim 5 ( 4%) Cefuroxime 0 (0%)
Sulphonamide 8 ( 6%) Cefotaxime 0 (0%)
All strains were sensitive to gentamicin, amoxycillin with clavulanic acid,
cefuroxime and cefotaxime. A small percentage ofthe ampicillin-sensitive strains
was resistant to tetracycline (6%), trimethoprim (4%), sulphonamide (6%) and
co-trimaxazole (6%). Among the ampicillin-resistant strains this percentage was
greater: 21 % for tetracycline, 14% for trimethoprim, 21 % for sulphonamide
and 21 % for co-trimoxazole. A significant percentage of both the ampicillin-
resistant strains (43%) and the ampicillin-sensitive strains (40%) was resistant to
erythromycin.
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DISCUSSION
This survey showed that 14 out of 150(9.3%) strains of Haemophilus influenzae
isolated from sputum were resistant to ampicillin - a figure roughly similar to
that obtained at some other centres in the U.K. Disc sensitivity testing of the 150
strains of Haemophilus influenzae to other antibiotics showed that cefuroxime,
cefotaxime, gentamicin, and amoxycillin with clavulanic acid were 100%
effective. Tetracycline, trimethoprim and co-trimoxazole showed good activity
against the ampicillin-sensitive strains but were less effective against the
ampicillin-resistant strains. These antibiotics could be useful alternatives in
patients who are allergic or have other side-effects to ampicillin or amoxycillin.
Trimethoprim may be preferable to co-trimoxazole because it has been shown to
be equally effective in adults with chronic bronchitis or with pneumonia, has
fewer side-effects (rashes, nausea etc.) and is marginally cheaper. Tetracycline
has been used for many years in the treatment of bronchial infections and still has
a place today. Erythromycin was only moderately active against both the
ampicillin-resistant strains (43%) and the ampicillin-sensitive strains (40%) and it
has only a limited place in the treatment of lower respiratory tract infections due
to Haemophilus influenzae.
In view of the trend towards increasing ampicillin resistance among isolates of
Haemophilus influenzae, other alternative antibiotics are likely to be ofincreasing
importance for the treatment of infections due to the organism. They should be
considered for patients not responding satisfactorily to ampicillin or amoxycillin
or when these.3-lactamase-producing strains of Haemophilus influenzae are
isolated on culture of sputum. In very ill patients in hospital, parenteral therapy
with one of the newer cephalosporins such as cefuroxime or cefotaxime would be
the drug of choice especially before the results of sensitivity test are available.
Gentamicin could also be used but it is a potentially toxic drug with a narrow
therapeutic margin and it has no useful activity against the pneumococcus which
is the other important pathogen in acute infective exacerbations of chronic
bronchitis. Among the oral agents, amoxycillin with clavulanic acid is the drug of
choice, although trimethoprim, co-trimoxazole and tetracycline may also be
useful.
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